Genetic Background of Hypertension in Connective Tissue Diseases

Abstract EN

Peroxisome proliferator-activated receptors (PPAR gamma-2) and beta-3-adrenergic receptors (ADRB3) are involved in the risk of hypertension.

But their exact role in blood pressure modulation in patients with connective tissue diseases (CTD) is still not well defined.

In this study, 104 patients with CTD and 103 gender- and age-matched controls were genotyped for Pro12Ala and C1431T polymorphisms of the PPAR gamma-2 gene and Trp64Arg polymorphism of the ADRB gene.

Anthropometric and biochemical measurements were evaluated, followed by genotyping using TaqMan® SNP genotyping assays and polymerase chain reaction-restriction fragment length polymorphism.

The prevalence of analyzed genotypes and alleles was comparable between patients with CTD and the control group, as well as hypertensive and normotensive subjects.

Patients with CTD have lower body fat and higher body water amount, serum glucose, and triglyceride (TG) levels.

Hypertensive subjects are older and have higher body mass, BMI, waist circumference (WC), body water content, glucose, and TG concentration.

The multivariate analysis revealed that hypertensive subjects with Ala12/X or Trp64Trp have higher body mass and WC when compared to normotensive subjects.

Trp64Trp polymorphism was also characterized by a higher TG level, while T1431/X subjects had higher WC.

The presence of CTD, visceral fat distribution, and increased age are the predictors of hypertension development.

Hypertensive patients with CTD and Trp64Trp polymorphism have an increased risk of visceral obesity development and metabolic complications, which in turn affects the value of blood pressure.

In addition, either Ala12/X or T1431/X predicts the visceral body fat distribution in hypertensive subjects.